| Screening of fifteen Indian ayurvedic plants for alpha-glucosidase inhibitory activity and enzyme kinetics JA Bachhawat, MS Shihabudeen, K Thirumurugan Int J Pharm Pharm Sci 3 (4), 267-74, 2011 | 123 | 2011 |
| WNK1 enhances migration and invasion in breast cancer models AB Jaykumar, JU Jung, PK Parida, TT Dang, C Wichaidit, AR Kannangara, ... Molecular cancer therapeutics 20 (10), 1800-1808, 2021 | 33 | 2021 |
| Role of Alström syndrome 1 in the regulation of blood pressure and renal function AB Jaykumar, PS Caceres, KN King-Medina, TD Liao, I Datta, D Maskey, ... JCI insight 3 (21), 2018 | 33 | 2018 |
| Real-time monitoring of NKCC2 endocytosis by total internal reflection fluorescence (TIRF) microscopy AB Jaykumar, PS Caceres, I Sablaban, BA Tannous, PA Ortiz American Journal of Physiology-Renal Physiology 310 (2), F183-F191, 2016 | 21 | 2016 |
| R1 Motif is the Major Actin Binding Domain of TRIOBP-4 J Bao, E Bielski, A Bachhawat, K Thirumurugan, S Kitajiri, T Sakamoto Biophysical Journal 104 (2), 647a, 2013 | 20 | 2013 |
| WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis AB Jaykumar, S Plumber, DM Barry, D Binns, C Wichaidit, M Grzemska, ... Proceedings of the National Academy of Sciences 119 (30), e2203743119, 2022 | 13 | 2022 |
| Control of podocyte and glomerular capillary wall structure and elasticity by WNK1 kinase Z Liu, J Yoon, C Wichaidit, AB Jaykumar, HA Dbouk, AE Embry, L Liu, ... Frontiers in Cell and Developmental Biology 8, 618898, 2021 | 8 | 2021 |
| Rare pathogenic variants in WNK3 cause X-linked intellectual disability S Küry, J Zhang, T Besnard, A Caro-Llopis, X Zeng, SM Robert, SS Josiah, ... Genetics in Medicine 24 (9), 1941-1951, 2022 | 7 | 2022 |
| WNK1 in malignant behaviors: A potential target for cancer? JU Jung, AB Jaykumar, MH Cobb Frontiers in Cell and Developmental Biology 10, 935318, 2022 | 5 | 2022 |
| Pulling a mast1 on cisplatin resistance AB Jaykumar, AS Karra, MH Cobb Cancer Cell 34 (2), 183-185, 2018 | 5 | 2018 |
| Deletion of ALMS1 (Alstrom Syndrome 1) enhances salt‐sensitive hypertension, and induces insulin resistance and obesity in rats. AB Jaykumar, P Caceres, EL Henson, WH Beierwaltes, PA Ortiz The FASEB Journal 31, 857.26-857.26, 2017 | 3 | 2017 |
| Expression of ALMS1 in podocytes: possible role in filtration function D Maskey, A Jayakumar, SR Monu, PA Ortiz The FASEB Journal 36, 2022 | 1 | 2022 |
| Single-molecule labeling for studying trafficking of renal transporters AB Jaykumar, PS Caceres, PA Ortiz American Journal of Physiology-Renal Physiology 315 (5), F1243-F1249, 2018 | 1 | 2018 |
| WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling AB Jaykumar, D Binns, CA Taylor IV, A Anselmo, SG Birnbaum, KM Huber, ... bioRxiv, 2024.06. 09.598125, 2024 | | 2024 |
| Predictive and Experimental Motif Interaction Analysis Identifies Functions of the WNK-OSR1/SPAK Pathway CA Taylor IV, JU Jung, SG Kankanamalage, J Li, M Grzemska, ... bioRxiv, 2024.06. 26.600905, 2024 | | 2024 |
| Role of WNK1/OSR1 in maintaining endothelial tight junction integrity A Jaykumar, S Plumber, S Stippec, S Earnest, M Cobb The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| ALMS1 deletion in rats causes hyperleptinemia, progressive obesity, and renal damage S Monu, K King‐Medina, A Jayakumar, P Ortiz The FASEB Journal 33 (S1), 867.4-867.4, 2019 | | 2019 |
| The function of WNK1/OSR1 in cell migration and angiogenesis A Jaykumar, S Earnest, K McGlynn, SG Kankanamalage, S Stippec, ... The FASEB Journal 32, 533.49-533.49, 2018 | | 2018 |
| Decreased Ability to Excrete a Na Load and Hypertension in the ALMS1 (Alstrom Syndrome 1) Knockout Rat KN King-Medina, AB Jaykumar, PA Ortiz Hypertension 70 (suppl_1), A103-A103, 2017 | | 2017 |
| Exaggerated Salt‐Sensitive Hypertension in the ALMS1 (Alstrom syndrome 1) Knockout Rat KN King‐Medina, A Jaykumar, P Ortiz The FASEB Journal 31, 855.4-855.4, 2017 | | 2017 |
